Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)

China flag China · Delayed Price · Currency is CNY
17.94
+0.21 (1.18%)
Apr 30, 2026, 2:14 PM CST
Market Cap2.18B +49.0%
Revenue (ttm)110.32M +39.2%
Net Income-183.27M
EPS-1.49
Shares Out123.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,076,088
Average Volume1,399,292
Open17.84
Previous Close17.73
Day's Range17.67 - 18.23
52-Week Range11.20 - 31.20
Beta0.25
RSI50.59
Earnings DateApr 23, 2026

About SHA:688670

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 449
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688670
Full Company Profile

Financial Performance

In 2025, SHA:688670's revenue was 112.88 million, an increase of 39.70% compared to the previous year's 80.80 million. Losses were -178.46 million, 90.9% more than in 2024.

Financial Statements